General Dermatology

Dermatology Times is recapping our exclusive expert interviews from the month of February.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news on phase 3 remibrutinib data for CIndU subtypes, psoriasis “super responders” on risankizumab, the approval of difamilast ointment, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

NIH Sister Study ties hair straightener use to higher pancreatic and thyroid cancer risk, but experts say methods limit certainty.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news on Biofrontera’s sNDA for Ameluz PDT in superficial BCC, 52-week data on rezpegaldesleukin for AD, the FDA's latest iPLEDGE REMS updates, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

As we celebrate Valentine's Day, Mona Shahriari, MD, FAAD; Neal Bhatia, MD; Peter Lio, MD; Lisa Swanson, MD; Lawrence Schachner, MD; Julie Karen, MD; and Glynis Ablon, MD, FAAD, share why they love dermatology.

At a recent IMCAS symposium with Merz Aesthetics, Bianca Viscomi, MD, revealed how menopause and skin collide through collagen loss, confidence dips, and multimodal fixes.

This issue highlights clinical insights relevant to inflammatory conditions in diverse populations, emphasizing practical strategies for everyday practice.

Catch up on the health and dermatology-related commercials that aired during the 2026 Super Bowl.

GLP-1 therapies represent a paradigm shift requiring dermatology to integrate metabolic, medical, and aesthetic care.

At SBS 2026, Karan Lal, MD, and Mohammad Goldust, MD, reveal how social media and AI reshape dermatology trust and care.

Michael Gold, MD, shares insights on safer device use, peptides, GLP-1s, acne, hair therapies, and more.

As SBS kicks off in South Beach Miami, scroll through faces familiar to Dermatology Times presenting at the symposium.

La Roche-Posay and the Oncology Nursing Society mark World Cancer Day with a first-of-its-kind tool, improving cancer care in patients with skin of color.

Clinicians assess chronic urticaria prevalence and impact, revealing gaps in understanding and treatment that affect patient care and outcomes.

Explore innovative treatments for skin conditions, including lebrikizumab for pemphigus and low-level laser therapy for hair loss.

James Del Rosso, DO, discusses diagnosis and treatment of mastocytosis and inflammatory conditions.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news on the FDA's breakthrough designation of litifilimab for CLE, data on bitopertin in EPP treatment, the role of icotrokinra in the psoriasis landscape, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.